跳至主要内容
临床试验/NCT01393418
NCT01393418已完成不适用

EPO: A Renal Biomarker After Cardiac Surgery

University of Michigan1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2010年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
1
主要终点
Renal injury/Failure

研究概览

简要总结

The purpose of the study is to evaluate kidney biomarkers and determine if there is a correlation between Erythropoietin (EPO) levels and acute kidney injury after cardiac surgery. An early biomarker for kidney injury may be helpful in identifying, monitoring and managing patients at risk for kidney failure after cardiac surgery. To evaluate Erythropoietin's role as a predictor of poor renal function in the immediate post-bypass period we plan to compare EPO levels to Neutrophil gelatinase-associated lipocalin (NGAL).

详细描述

Acute kidney injury (AKI) is a serious complication after cardiac surgery and cardio-pulmonary bypass. AKI is associated with high mortality.

Erythropoietin, a hormone produced by the kidneys, will be evaluated as a potential biomarker of kidney injury. Neutrophil gelatinase-associated lipocalin (NGAL) has been studied as a biomarker of kidney injury. Early kidney injury detection has been long sought and NGAL has been shown to be a promising biomarker. A troponinlike biomarker of AKI that is easily measured and capable of both early detection and risk stratification would represent an advancement in our ability to differentiate acute kidney injury from failure.

Investigating EPO as a biomarker may prove to have increased predictive value in the clinical care of cardiac surgery patients.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Cardiac surgery with cardiopulmonary bypass with DHCA
  • Normal renal function or renal insufficiency-serum creatinine less than 2.5 mg/dL
  • Adult male and female patients 18 years and older

排除标准

  • Emergent cases
  • Prolonged hypoxemia before, during or after bypass
  • End stage renal disease
  • Patients receive erythropoietin receptor agonists

结局指标

主要结局

Renal injury/Failure

时间窗: 18 Hours after surgery

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yasser Kouatli

Clinical Lecturer

University of Michigan

研究点 (1)

Loading locations...

相似试验